BLOOMINGDALE, IL
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)CHILDREN'S NEUROBLASTOMA CANCER FOUNDATION, founded in 2000, is a small nonprofit in the Diseases & Disorders sector that reported $257K in total revenue in fiscal year 2023. Revenue decreased 12% compared to the prior year. Expenses of $352K exceeded revenue, resulting in a 37% operating deficit.
TO ASSIST IN FINDING A CURE FOR NEUROBLASTOMA CANCER IN CHILDREN; TO EDUCATE THE PUBLIC AND PEDIATRICIANS CONCERNING THE ABOVE CANCERS AND CONCERNING THE NEED FOR INCREASING FUNDING FOR THE DETECTION, TREATMENT AND ULTIMATE CURE OF THESE CANCERS; TO PROVIDE GRANTS FOR SUPPORT OF RESEARCH STUDIES.
THE NEUROBLASTOMA CANCER CONFERENCE AND RELATED EVENTS HELP EDUCATE PARENTS, CAREGIVERS, AND YOUNG ADULT PATIENTS TO FIND CLINICAL TRIALS FOR TREATMENT AND LEARN ABOUT CURRENT RESEARCH THAT IS BEING...
THE NEUROBLASTOMA CANCER CONFERENCE AND RELATED EVENTS HELP EDUCATE PARENTS, CAREGIVERS, AND YOUNG ADULT PATIENTS TO FIND CLINICAL TRIALS FOR TREATMENT AND LEARN ABOUT CURRENT RESEARCH THAT IS BEING CONDUCTED. A PARENT HANDBOOK IS PROVIDED TO ALL FAMILIES AFFECTED BY NEUROBLASTOMA. VOLUNTEERS HELP AT NUMEROUS FUNDRAISING EVENTS THROUGHOUT THE YEAR.
THE ORGANIZATION TYPICALLY ISSUES GRANTS ANNUALLY FOR NEUROBLASTOMA RESEARCH.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $257,127 | $290,764 | -0.1% |
| Expenses | $351,532 | $430,875 | -0.2% |
| Net Income | $-94,405 | $-140,111 | -0.3% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| PATRICIA TALLUNGAN | PRESIDENT/TREASURER | 40.00 |
Officer
Director
|
$70,000 | $0 | $70,000 |
| BRIAN NOONAN | DIRECTOR | 0.50 |
Director
|
$0 | $0 | $0 |
| MICHAEL TALLUNGAN | DIRECTOR | 0.50 |
Director
|
$0 | $0 | $0 |
| NATHAN TALLUNGAN | DIRECTOR/SECRETARY | 0.50 |
Officer
Director
|
$0 | $0 | $0 |
| STEPHANIE TALLUNGAN | DIRECTOR | 0.50 |
Director
|
$0 | $0 | $0 |
| PATTI POZELLA | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| KAREN CONTI | DIRECTOR | 0.50 |
Director
|
$0 | $0 | $0 |
| JENNIFER HUNTER | VICE PRESIDENT | 0.50 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $257,127 | $351,532 | $138,491 | $-94,405 |
| 2022 | $290,764 | $430,875 | $250,457 | $-140,111 |
| 2021 | $325,118 | $209,856 | $401,606 | $115,262 |
| 2020 | $258,172 | $232,071 | $304,217 | $26,101 |
| 2019 | $319,061 | $307,819 | $324,204 | $11,242 |
| 2018 | $315,024 | $360,813 | $221,336 | $-45,789 |
Compare CHILDREN'S NEUROBLASTOMA CANCER FOUNDATION with other nonprofits in Illinois and across the country.